|
1
|
Yu MC and Yuan JM: Epidemiology of
nasopharyngeal carcinoma. Semin Cancer Biol. 12:421–429. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chow E, Payne D, O’Sullivan B, Pintilie M,
Liu FF, Waldron J, Warde P and Cummings B: Radiotherapy alone in
patients with advanced nasopharyngeal cancer: comparison with an
intergroup study. Is combined modality treatment really necessary?
Radiother Oncol. 63:269–274. 2002. View Article : Google Scholar
|
|
3
|
Fritsch C, Goerz G and Ruzicka T:
Photodynamic therapy in dermatology. Arch Dermatol. 134:207–214.
1998. View Article : Google Scholar
|
|
4
|
Roscetti G, Franzese O, Comandini A and
Bonmassar E: Cytotoxic activity of Hypericum perforatum L on K562
erythroleukemic cells: differential effects between methanolic
extract and hypericin. Phytother Res. 18:66–72. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kiesslich T, Krammer B and Plaetzer K:
Cellular mechanisms and prospective applications of hypericin in
photodynamic therapy. Curr Med Chem. 13:2189–2204. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim CH, Chung CW, Choi KH, Yoo JJ, Kim do
H, Jeong YI and Kang DH: Effect of 5-aminolevulinic acid-based
photodynamic therapy via reactive oxygen species in human
cholangiocarcinoma cells. Int J Nanomed. 6:1357–1363.
2011.PubMed/NCBI
|
|
7
|
Kamoshima Y, Terasaka S, Kuroda S and
Iwasaki Y: Morphological and histological changes of glioma cells
immediately after 5-aminolevulinic acid mediated photodynamic
therapy. Neurol Res. 33:739–746. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park JH, Moon YH, Kim DJ, Kim SA, Lee JB,
Ahn SG and Yoon JH: Photodynamic therapy with hexenyl ester of
5-aminolevulinic acid induces necrotic cell death in salivary gland
adenocarcinoma cells. Oncol Rep. 24:177–181. 2010.PubMed/NCBI
|
|
9
|
Los M, Wesselborg S and Schulze-Osthoff K:
The role of caspases in development, immunity, and apoptotic signal
transduction: lessons from knockout mice. Immunity. 10:629–639.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schwerk C and Schulze-Osthoff K:
Regulation of apoptosis by alternative pre-Mrna splicing. Mol Cell.
19:1–13. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fischer U, Jänicke RU and Schulze-Osthoff
K: Many cuts to ruin: a comprehensive update of caspase substrates.
Cell Death Differ. 10:76–100. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Noteborn MH, Todd D, Verschueren CA, de
Gauw HW, Curran WL, Veldkamp S, Douglas AJ, McNulty MS, van der
EBAJ and Koch G: A single chicken anemia virus protein induces
apoptosis. J Virol. 68:346–351. 1994.PubMed/NCBI
|
|
13
|
Maddika S, Mendoza FJ, Hauff K, Zamzow CR,
Paranjothy T and Los M: Cancer selective therapy of the future:
apoptin and its mechanism of action. Cancer Biol Ther. 5:10–19.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Noteborn MH: Chicken anemia virus induced
apoptosis: underlying molecular mechanisms. Vet Microbiol.
98:89–94. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Heilman DW, Teodoro JG and Green MR:
Apoptin nucleocytoplasmic shuttling is required for cell
type-specific localization, apoptosis, and recruitment of the
anaphase-promoting complex/cyclosome to PML bodies. J Virol.
80:7535–7545. 2006. View Article : Google Scholar
|
|
16
|
Poon IK, Oro C, Dias MM, Zhang J and Jans
DA: Apoptin nuclear accumulation is modulated by a CRM1-recognized
nuclear export signal that is active in normal but not in tumor
cells. Cancer Res. 65:7059–7064. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Backendorf C, Visser AE, de Boer AG,
Zimmerman R, Visser M, Voskamp P, Zhang YH and Noteborn M: Apoptin:
therapeutic potential of an early sensor of carcinogenic
transformation. Annu Rev Pharmacol Toxicol. 48:143–169. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tavassoli M, Guelen L, Luxon BA and Gäken
J: Apoptin: specific killer of tumor cells? Apoptosis. 10:717–724.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhuang SM, Shvarts A, van Ormondt H,
Jochemsen AG, van der Eb AJ and Noteborn MH: Apoptin, a protein
derived from chicken anemia virus, induces p53-independent
apoptosis in human osteosarcoma cells. Cancer Res. 55:486–489.
1995.PubMed/NCBI
|
|
20
|
Burek M, Maddika S, Burek CJ, Daniel PT,
Schulze-Osthoff K and Los M: Apoptin-induced cell death is
modulated by Bcl-2 family members and is Apaf-1 dependent.
Oncogene. 25:2213–2222. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie Y, Wei ZB, Zhang Z, Wen W and Huang
GW: Effect of 5-ALA-PDT on VEGF and PCNA expression in human
NPC-bearing nude mice. Oncol Rep. 22:1365–1371. 2009.PubMed/NCBI
|
|
22
|
Krieger MD, Couldwell WT and Weiss MH:
Assessment of long term remission of acromegaly following surgery.
J Neurosurg. 98:719–724. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barnes LD, Giuliano EA, Ota J, Cohn LA and
Moore CP: The effect of photodynamic therapy on squamous cell
carcinoma in a murine model: evaluation of time between
intralesional injection to laser irradimion. Vet J. 180:60–65.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yung A, Stables GI, Fernandez C, Williams
J, Boiar RA and Goulden V: Microbiological effect of photodynarnic
therapy(PDT) in healthy volunteers: a comparative study using
methyl aminolaevulinate and hexyl aminolaevulinate cream. Clin Exp
Dermatol. 32:716–721. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Su ZA, Yao K, Shen J, Jiang JK, Fang XY,
Lin JJ and DU XH: Evaluation of photodynamic therapy in idiopathic
choroidal neovascularization. Zhonghua Yan Ke Za Zhi. 43:509–513.
2007.PubMed/NCBI
|
|
26
|
Luna MC, Chen X, Wong S, Tsui J, Rucker N,
Lee AS and Gomer CJ: Enhanced photodynamic therapy efficacy with
inducible suicide gene therapy controlled by the grp promoter.
Cancer Res. 62:1458–1461. 2002.PubMed/NCBI
|
|
27
|
Laden BP, Tang Y and Porter TD: Cloning,
heterologous expression, andenzymological characterization of human
squalene monooxygenase. Arch Biochem Biophys. 374:381–388. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Teodoro JG, Heilman DW, Parker AE and
Green MR: The viral protein Apoptin associates with the
anaphase-promoting complex to induce G2/M arrest and apoptosis in
the absence of p53. Genes Dev. 18:1952–1957. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Danen-van Oorschot AA, Voskamp P, Seelen
MC, van Miltenburg MH, Bolk MW, Tait SW, Boesen-de Cock JG, Rohn
JL, Borst J and Noteborn MH: Human death effector domain-associated
factor interacts with the viral apoptosis agonist Apoptin and
exerts tumor-preferential cell killing. Cell Death Differ.
11:564–573. 2004.
|
|
30
|
Janssen K, Hofmann TG, Jans DA, Hay RT,
Schulze-Osthoff K and Fischer U: Apoptin is modified by SUMO
conjugation and targeted to promyelocytic leukemia protein nuclear
bodies. Oncogene. 26:1557–1566. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Krieghoff-Henning E and Hofmann TG: Role
of nuclear bodies in apoptosis signaling. Biochim Biophys Acta.
1783:2185–2194. 2008. View Article : Google Scholar : PubMed/NCBI
|
